• Bioverativ, Bicycle Therapeutics Partner to Develop Sickle Cell Disease Therapeutics
  • CSL Behring’s Acquisition of Calimmune May Spur New Therapies to Treat Sickle Cell Disease
  • Opioid Abuse Backlash Could Hurt Sickle Cell Patients’ Medication Needs, Some Fear
  • Computer Model Reveals Underlying Mechanism of Hemoglobin S Fibers in Sickle Cell Disease
  • Stanford Center Hopes to Take Stem Cell and Gene Therapies to a New Level
  • Hematology and Sickle Cell Experts Take Top Children’s National Hospital Posts
  • AbbVie’s Imbruvica is First Approved Treatment for Adults with Chronic Graft-Versus-Host-Disease
  • Sancilio Completes Enrollment in Clinical Trial of Altemia as Treatment for Children with Sickle Cell Conditions
  • Gamida Cell Receives $3.5M Grant from Israeli Government to Help Develop CordIn Therapy
  • ‘Natural’ Gene Mutation May Offer Way of Treating Sickle Cell Disease, Study Says
  • Sema4 and Helix Launch CarrierCheck, a Genetic Screen of 67 Hereditary Diseases
  • Quest Diagnostics Launches Genetic Test to Assess Risk for Sickle Cell Anemia, Other Inherited Disorders